Gossamer Bio, Inc. (GOSS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1246880,
    "name": "Gossamer Bio, Inc.",
    "stock_name": "Gossamer Bio, Inc.",
    "full_name": "Gossamer Bio, Inc.",
    "name_url": "stocks-analysis/gossamer-bio-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "3.32",
    "chg": 0.33,
    "chgp": "11.04%",
    "dir": 1,
    "prev_price": "2.99",
    "mcapval": "607.29",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US38341P1021",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "4.38 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gossamer-bio-inc-1246880-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Gossamer Bio, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-gossamer-bio-inc-technically-bullish-or-bearish-3617687",
        "imagepath": "",
        "date": "2025-10-14 11:38:29",
        "description": "As of 10 October 2025, the technical trend for Gossamer Bio, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating a positive momentum. The Bollinger Bands are also showing a mildly bullish stance on both weekly and monthly time frames. However, the Dow Theory presents a mixed view with a mildly bearish signal on the weekly and a mildly bullish signal on the monthly. The moving averages on the daily chart are mildly bullish, but the weekly OBV is mildly bearish, suggesting some selling pressure. Overall, the indicators suggest a mildly bullish stance, but with caution due to mixed signals in the Dow Theory and OBV. Multi-period return data is not available for comparison with the S&P 500...."
      },
      {
        "title": "Is Gossamer Bio, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-gossamer-bio-inc-technically-bullish-or-bearish-3614684",
        "imagepath": "",
        "date": "2025-10-13 11:40:07",
        "description": "As of 10 October 2025, the technical trend for Gossamer Bio, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating a positive momentum. The Bollinger Bands are also showing a mildly bullish stance on both weekly and monthly time frames. However, the Dow Theory presents a mixed view with a mildly bearish signal on the weekly and mildly bullish on the monthly. The moving averages are mildly bullish on the daily timeframe. Overall, the indicators suggest a mildly bullish stance, but the mixed signals from Dow Theory and OBV, which is mildly bearish weekly and mildly bullish monthly, indicate some caution. There is no available return data for comparison with the S&P 500...."
      },
      {
        "title": "Is Gossamer Bio, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-gossamer-bio-inc-technically-bullish-or-bearish-3613019",
        "imagepath": "",
        "date": "2025-10-12 11:27:52",
        "description": "As of 10 October 2025, the technical trend for Gossamer Bio, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The Bollinger Bands indicate a mildly bullish stance for both weekly and monthly periods. Daily moving averages are also mildly bullish. However, the Dow Theory shows a mildly bearish signal on the weekly timeframe, contrasting with a mildly bullish monthly outlook. The KST is bullish for both weekly and monthly periods, but the OBV indicates a mildly bearish weekly trend and a mildly bullish monthly trend.\n\nIn terms of performance, Gossamer Bio has significantly outperformed the S&P 500 year-to-date with a return of 152.05% compared to the S&P 500's 11.41%, but it has underperformed over the last month with a return of -26.69% against the S&P 500's 0.31%. Overall, the current technical stance is mildly bullish, driven by the mixe..."
      },
      {
        "title": "Is Gossamer Bio, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-gossamer-bio-inc-technically-bullish-or-bearish-3547834",
        "imagepath": "",
        "date": "2025-09-20 20:04:06",
        "description": "As of 21 August 2025, the technical trend for Gossamer Bio, Inc. has changed from mildly bullish to bullish. The current technical stance is bullish, with strong indicators from the daily moving averages and weekly MACD. However, the monthly RSI remains bearish, indicating some caution. The Bollinger Bands are bullish on a monthly basis, supporting the overall bullish sentiment. \n\nIn terms of multi-period returns, the stock has significantly outperformed the S&P 500 year-to-date with a return of 240.48% compared to the S&P 500's 12.22%, and over the past year, it has returned 238.05% against the S&P 500's 17.14%...."
      },
      {
        "title": "Is Gossamer Bio, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-gossamer-bio-inc-overvalued-or-undervalued-3544084",
        "imagepath": "",
        "date": "2025-09-20 18:37:16",
        "description": "As of 12 August 2024, Gossamer Bio, Inc. has moved from a grade of \"does not qualify\" to \"risky.\" The company appears to be overvalued given its negative valuation ratios, including a Price to Book Value of -48.57, an EV to EBIT of -4.46, and an EV to EBITDA of -4.76. In comparison to peers, Rigel Pharmaceuticals, Inc. has a much more favorable P/E ratio of 7.49 and an EV to EBITDA of 6.40, highlighting the significant disparity in valuation.\n\nDespite a strong year-to-date return of 240.48%, which outperformed the S&P 500's 12.22%, the long-term performance is concerning, with a 3-year return of -77.22% compared to the S&P 500's 70.41%. This indicates that while there may be short-term volatility, the overall valuation metrics suggest that Gossamer Bio, Inc. is not a sound investment at its current price...."
      }
    ],
    "total": 10,
    "sid": "1246880",
    "stock_news_url": "https://www.marketsmojo.com/news/gossamer-bio-inc-1246880"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Gossamer Bio, Inc. technically bullish or bearish?

2025-10-14 11:38:29

As of 10 October 2025, the technical trend for Gossamer Bio, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating a positive momentum. The Bollinger Bands are also showing a mildly bullish stance on both weekly and monthly time frames. However, the Dow Theory presents a mixed view with a mildly bearish signal on the weekly and a mildly bullish signal on the monthly. The moving averages on the daily chart are mildly bullish, but the weekly OBV is mildly bearish, suggesting some selling pressure. Overall, the indicators suggest a mildly bullish stance, but with caution due to mixed signals in the Dow Theory and OBV. Multi-period return data is not available for comparison with the S&P 500....

Is Gossamer Bio, Inc. technically bullish or bearish?

2025-10-13 11:40:07

As of 10 October 2025, the technical trend for Gossamer Bio, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating a positive momentum. The Bollinger Bands are also showing a mildly bullish stance on both weekly and monthly time frames. However, the Dow Theory presents a mixed view with a mildly bearish signal on the weekly and mildly bullish on the monthly. The moving averages are mildly bullish on the daily timeframe. Overall, the indicators suggest a mildly bullish stance, but the mixed signals from Dow Theory and OBV, which is mildly bearish weekly and mildly bullish monthly, indicate some caution. There is no available return data for comparison with the S&P 500....

Is Gossamer Bio, Inc. technically bullish or bearish?

2025-10-12 11:27:52

As of 10 October 2025, the technical trend for Gossamer Bio, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The Bollinger Bands indicate a mildly bullish stance for both weekly and monthly periods. Daily moving averages are also mildly bullish. However, the Dow Theory shows a mildly bearish signal on the weekly timeframe, contrasting with a mildly bullish monthly outlook. The KST is bullish for both weekly and monthly periods, but the OBV indicates a mildly bearish weekly trend and a mildly bullish monthly trend. In terms of performance, Gossamer Bio has significantly outperformed the S&P 500 year-to-date with a return of 152.05% compared to the S&P 500's 11.41%, but it has underperformed over the last month with a return of -26.69% against the S&P 500's 0.31%. Overall, the current technical stance is mildly bullish, driven by the mixe...

Is Gossamer Bio, Inc. technically bullish or bearish?

2025-09-20 20:04:06

As of 21 August 2025, the technical trend for Gossamer Bio, Inc. has changed from mildly bullish to bullish. The current technical stance is bullish, with strong indicators from the daily moving averages and weekly MACD. However, the monthly RSI remains bearish, indicating some caution. The Bollinger Bands are bullish on a monthly basis, supporting the overall bullish sentiment. In terms of multi-period returns, the stock has significantly outperformed the S&P 500 year-to-date with a return of 240.48% compared to the S&P 500's 12.22%, and over the past year, it has returned 238.05% against the S&P 500's 17.14%....

Is Gossamer Bio, Inc. overvalued or undervalued?

2025-09-20 18:37:16

As of 12 August 2024, Gossamer Bio, Inc. has moved from a grade of "does not qualify" to "risky." The company appears to be overvalued given its negative valuation ratios, including a Price to Book Value of -48.57, an EV to EBIT of -4.46, and an EV to EBITDA of -4.76. In comparison to peers, Rigel Pharmaceuticals, Inc. has a much more favorable P/E ratio of 7.49 and an EV to EBITDA of 6.40, highlighting the significant disparity in valuation. Despite a strong year-to-date return of 240.48%, which outperformed the S&P 500's 12.22%, the long-term performance is concerning, with a 3-year return of -77.22% compared to the S&P 500's 70.41%. This indicates that while there may be short-term volatility, the overall valuation metrics suggest that Gossamer Bio, Inc. is not a sound investment at its current price....

View All News